This inventor holds 2 USPTO granted patents. Top assignee: Xybernaut Corporation. Active years: 1998-2003.
Company Filing History:
Years Active: 1998-2003
Title: Innovations by Amin Tjota in Celiac Disease Screening
Introduction
Amin Tjota is an accomplished inventor based in Williamsville, NY (US). He has made significant contributions to the field of medical diagnostics, particularly in the screening of celiac disease. With a total of 2 patents to his name, Tjota's work is paving the way for improved patient care.
Latest Patents
Tjota's latest patents focus on a novel antigen for screening patients suspected of having celiac disease. The first patent describes a process that begins with human placenta tissue, which is perfused with a hepes and collagenase buffer to create a single cell suspension. This suspension is then enriched to obtain an enriched protein portion, which is separated to yield an embryonic celiac antigen (ECA). The ECA is utilized with serum from patients to facilitate the binding of ECA with IgA in the serum, while a human IgA antibody is applied. The results are analyzed using a spectrophotometer to confirm or negate the presence of celiac disease. The second patent reiterates this innovative approach, emphasizing the importance of the ECA in diagnosing celiac disease.
Career Highlights
Amin Tjota is associated with Xybernaut Corporation, where he continues to develop groundbreaking technologies in the medical field. His work has garnered attention for its potential to enhance diagnostic accuracy and patient outcomes.
Conclusion
Amin Tjota's contributions to the field of celiac disease screening through his innovative patents demonstrate his commitment to advancing medical diagnostics. His work not only highlights the importance of research and innovation but also reflects the potential for improved healthcare solutions.